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The results of systemic chemotherapy for treatment of many
of the solid tumours are poor. Regional chemotherapy is an
attractive concept which aims to improve tumour drug
exposure and reduce systemic toxicity by delivering the
cytotoxic in concentrated from directly to the tumour-bearing
organ. via its arterial supply.
In the absence of new agents with specific activity and
acceptable toxicity. attention has turned to methods of
enhancing the effect of drugs which are currently available.
Novel formulations of established cvtotoxics can be svn-
thesised which are particularly applicable to regional
delivery. Willmott and co-workers (1985) have described
Adriamvcin loaded albumin microspheres - particles with a
diameter of 20-40 gm which are made by glutaraldehyde
stabilisation of an oil in water emulsion.
Early animal experiments with regionally administered
albumin microspheres confirmed almost complete embolisa-
tion of particles within a target organ. and showed that the
microspherical formulation was associated with little svstemic
drug exposure (McArdle et al.. 1988).
The aim of the present study was to assess the anti-tumour
effect of Adriamvcin-loaded albumin microspheres given
regionally in a rat tumour model.
Aggregate-free suspensions of Adriamycin-loaded micro-
spheres were made by a technique based on that of Lee and
colleagues. 1981. The particles were filtered to obtain a
diameter of between 20 and 40 g.m. 50% weight average
(Willmott et al.. 1985).
The quantity of Adriamycin within the particles was
evaluated by HPLC (Cummings & Willmott. 1985). Two
milligrams of microspheres contained approximately 10 gg of
.native' Adriamycin, and 20 jig of covalently bound drug.
Three day old hepatic tumour implants of Walker 256
(70 mg) in Sprague-Dawley rats (600-700 g) were used in
this study (Ackerman et al., 1969). Model characterisation
studies using hepatic arterial and portal venous injections of
radiolabelled microspheres had shown that the tumour vas-
culature was derived almost exclusively from the hepatic
artery and that the arterial perfusion of tumours was propor-
tionally higher than that of the surrounding normal liver
parenchyma. Arterio-venous shunting was minimal (Gold-
berg, 1990).
Four groups of six tumour-bearing animals were starved
for 12 h; under ether anaesthesia, all underwent laparotomy
for temporary cannulation of the gastroduodenal artery,
which allowed infusion of one of the following via the
hepatic artenral stream:
I Intra-arterial normal saline (50 l).
II Intra-arterial empty albumin microspheres (2 mg in
50pd).
III Intra-arterial Adriamycin 30 ig in 50 gl.
IV Intra-arterial Adriamycin loaded microspheres (2 mg
containing approximately 30 Ig of Adnramycin in
50pl).
The animals were recovered and allowed free access to
food and water.
On the seventh day after tumour implantation. the animals
were culled. the tumours excised from the liver parenchyma
and weighed blind. Both tumour and normal liver were
preserved for histological and fluorescent microscopic detec-
tion of Adnramycin.
The tumour weights of each group at cull were compared
using the Mann-Whitney test.
The results are summarised in Table I. The mean tumour
weight at cull was significantly lower in the group of animals
treated with Adriamycin loaded albumin microspheres.
Pathological assessment showed no obvious differences
between the groups in terms of the relative amount of
remaining viable tissues within the tumour nidus. Fragments
of microspheres could be seen within tumour from the
animals in groups II and IV (Figure 1).
Fluorescent microscopy detected considerable amounts of
Adriamvcin in the liver and tumour of animals treated with
drug-loaded microspheres (Figure 2). whereas no drug
remained in the tissues of animals treated with drug in
solution. Intracellular Adnramycin was demonstrated in the
tumour and liver of animals which had received the drug
loaded particles.
The systemic treatment of many solid tumours by chemo-
therapy has yielded disappointing results. This has led to
increasing interest in regional chemotherapy. but the
theoretical advantages of arterial drug administration are not
always apparent in practice.
The magnitude of the gain in regional selectivity depends
upon factors such as saturation of the mechanism for drug
extraction by the target organ, and the presence of arterio-
venous shunts. The advantage of a regional approach to drug
aministration is difficult to assess directly in patients:
pharmacokinetic studies create a broad overview of systemic
exposure, but yield no information about tumour drug levels
or metabolism.
The data presented here suggest that the drug loaded
particles are more potent in their anti-tumour effect than the
drug in solution. The demonstration of intracellular drug in
target tissue 4 days after microsphere infusion suggests that
Adriamycin-loaded albumin microspheres have 'slow-release'
properties in vivo which sustain high target-tissue drug levels
for much longer than those achieved with regional admini-
stration of the drug in solution.
There is other in vivo evidence to suggest that native
Adriamycin incorporated within microspheres might indeed
Table I Mean weight of implant 4 days following treatment
Mean tunour
Group n weight (grams) SD
I 6 0.73 0.16
II 6 1.01 0.27
III 6 0.74 0.12
IV 6 0.45 0.08a
Group I: IA Normnal saline: Group II: IA Albumin microspheres;
Group III: IA Adriamycin in solution: Group IV: IA Adriamv-
cin-loaded albumin microspheres. 'P<0.05. Mann-Whitne
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Figure 1 Histological section (haemotoxyhn and eosin) of Walker 256 intrahepatic implant. This animal had been treated with an
injection of Adriamycin-loaded albumin microspheres 4 days prior to cull. Intra-arterial fragments of drug-loaded particles can be
seen within viable tumour in the centre of the field. Tumour tissue is seen on the left (necrotic) and centre (viable) of the field:
normal liver parenchyma is seen on the right of the field.
Fiwe 2 Fluorescent micrograph of tumour tissue from an animal treated with Adriamycin-loaded albumin microspheres 4 days
prior to cull. Intravascular fragments ofdrug-loaded particles can be seen containing a high concentration of Adriamycin, resulting
in the intense fluorescence. However, the presence of an overall background fluorescence throughout the section shows that drug is
present within the tissue at an intracellular level. In fluorescent micrographs of tumour from animals treated with a similar dose of
drug in solution, no drug could be detected.ADRIAMYCIN-LOADED ALBUMIN MICROSPHERES 395
be more potent than the free drug (Willmott & Cummings.
1987). It has been shown that native Adnramycin in micro-
spherical form is metabolised in tumour tissue via a reductive
pathway. raising the possibility of reactive drug inter-
mediates. More recent work, however, suggests that for
Adriamycin. it is the sustained release properties of micro-
spheres which are important for anti-tumour activity, rather
than induction of reductive drug metabolism (Willmott et al..
1990). Sustained release and increased exposure to
Adriamycin is clearly illustrated in Figures 1 and 2.
These reports support other work which suggests that drug
delivery systems can confer new and unexpected modes of
action of drugs incorporated within particles, as well as
changing drug disposition (Tritton & Yee. 1982. Rogers &
Tokes. 1984; Mehta et al.. 1984). It is this aspect of micro-
sphere bound regional chemotherapy which has the greatest
potential because it is possible that the potency of existing
cytotoxic drugs may be increased.
The myocardial toxicity associated with systemic admini-
stration of Adriamycin limits the cumulative dose in patients
to 450 mg m 2. However, a microsphere bound formulation
ofAdnramycin administered regionally., which greatly reduced
systemic exposure and achieved imnproved response rates at
lower drug dosage. would increase its therapeutic potential
and allow dose escalation.
This study has shown that Adriamycin-loaded albumin
microspheres can suppress tumour growth in an animal
model. The use of regionally administered particulate drug
formulations may offer a new approach in the management
of solid tumours refractory to treatment by conventional
therapy.
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